Supporting Lentiviral Vector Development

resourcesSIRION Biotech GmbH
November 4th 2022

Supporting Lentiviral Vector Development for safer and more efficacious cell therapies. Sirion provides a 360° solution beginning from the early R&D to the late preclinical lentivirus space to support development of safe and efficacious lentiviral vector-based cell therapies. Please click on the brochure below to learn more:

Succeed with Sirion

LentiBOOST® - Lentiviral Transduction Enhancer For Clinical Applications

FREE DOWNLOAD

SIRION Biotech GmbH

Contact Information
Address: Am Haag 6, 82166 Graefelfing, Germany
Telephone No: +49 89 700 961 99 0
Email Address: [email protected]